DOYLE JOHN BRENDAN (Chief Financial Officer) purchased 1.6% of their position (10K shares) of COGNITION THERAPEUTICS INC on the open market
Open‑market purchase worth $11.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/20/2026ACC: 0001104659-26-045511
Officer· Chief Financial Officer
Since Feb 2026
+10K
Net shares
Net buyer
$11.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$1.13
Trade value
$11.30K
% of position
1.6%
4/16/2026
617.51K→627.51K
Total
Net shares
+10K
Net value
$11.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | P · Purchase | +10K | $1.13 | $11.30K | 1.6% | 617.51K | 627.51K |
| Total | +10K | $11.30K | ||||||
Derivative Transactions0
No derivative transactions reported